(Q40455461)

20 September 2017

G to A hypermutation of hepatitis B virus. (English)

1 reference

20 September 2017

1 reference

7

Kazuaki Chayama

1 reference

20 September 2017

5

Michio Imamura

1 reference

20 September 2017

3

Masataka Tsuge

1 reference

20 September 2017

6

Shoichi Takahashi

1 reference

20 September 2017

Chiemi Noguchi

1

1 reference

20 September 2017

Hiromi Ishino

series ordinal

2

1 reference

20 September 2017

Yoshifumi Fujimoto

series ordinal

4

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

20 September 2017

1 reference

20 September 2017

41

1 reference

20 September 2017

3

1 reference

20 September 2017

626-633

1 reference

Clinical aspects of hepatitis B virus infection

20 September 2017

1 reference

7 January 2021

Hepatitis B virus and hepatocellular carcinoma

1 reference

7 January 2021

Clinical virology of hepatitis B virus infection

1 reference

7 January 2021

Hepatitis B virus infection--natural history and clinical consequences

1 reference

7 January 2021

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

1 reference

7 January 2021

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

1 reference

7 January 2021

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

1 reference

7 January 2021

DNA deamination mediates innate immunity to retroviral infection

1 reference

7 January 2021

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

1 reference

7 January 2021

APOBEC3G targets specific virus species.

1 reference

7 January 2021

The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity.

1 reference

7 January 2021

Functional domains of APOBEC3G required for antiviral activity

1 reference

7 January 2021

Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.

1 reference

7 January 2021

Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway

1 reference

7 January 2021

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

1 reference

7 January 2021

HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability

1 reference

7 January 2021

Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G-->A hypermutation

1 reference

7 January 2021

Inhibition of hepatitis B virus replication by APOBEC3G.

1 reference

7 January 2021

Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping

1 reference

7 January 2021

Detecting hypermutations in viral sequences with an emphasis on G --> A hypermutation

1 reference

7 January 2021

PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules

1 reference

7 January 2021

Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases

1 reference

7 January 2021

In vitro infection of human peripheral blood mononuclear cells by a defective hepatitis B virus with a deletion in the PreS1 region of the viral genome

1 reference

7 January 2021

Detection of pre-S1 proteins in peripheral blood mononuclear cells from patients with HBV infection

1 reference

7 January 2021

Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen

1 reference

7 January 2021

Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection

1 reference

7 January 2021

Comment on "Inhibition of hepatitis B virus replication by APOBEC3G".

1 reference

7 January 2021

Hypermutation of HIV type 1 genomes isolated from infants soon after vertical infection.

1 reference

7 January 2021

Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes

1 reference

7 January 2021

Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells

1 reference

7 January 2021

A highly defective HIV-1 group O provirus: evidence for the role of local sequence determinants in G-->A hypermutation during negative-strand viral DNA synthesis

1 reference

7 January 2021

Lentiviral genomes with G-to-A hypermutation may result from Taq polymerase errors during polymerase chain reaction

1 reference

7 January 2021

Quality control by DNA repair

1 reference

7 January 2021

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

1 reference

7 January 2021

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20580

1 reference

20 September 2017

1 reference